Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04657991 |
|---|---|
| Brief Title: | A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma |
| First Submitted : | December 1, 2020 |
| First Submitted that Met QC Criteria : | December 1, 2020 |
| First Posted : | December 8, 2020 |
| Last Update Submitted that Met QC Criteria : | March 15, 2023 |
| Last Update Posted : | March 20, 2023 |